 | • レポートコード：B-GIR08C4147 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、オピオイド耐性治療の世界市場について調べ、まとめました。種類別セグメントは、NMDA拮抗薬、α2 - アドレナリン受容体作動薬等、用途別セグメントは、病院・外来手術センター、リハビリテーションセンター等に区分しました。オピオイド耐性治療の世界市場概観、企業動向、企業別オピオイド耐性治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・オピオイド耐性治療の市場概観 ・オピオイド耐性治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・オピオイド耐性治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・オピオイド耐性治療の世界市場規模 ・オピオイド耐性治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・オピオイド耐性治療のアメリカ市場規模推移 ・オピオイド耐性治療のカナダ市場規模推移 ・オピオイド耐性治療のメキシコ市場規模推移 ・オピオイド耐性治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・オピオイド耐性治療のドイツ市場規模推移 ・オピオイド耐性治療のイギリス市場規模推移 ・オピオイド耐性治療のロシア市場規模推移 ・オピオイド耐性治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・オピオイド耐性治療の日本市場規模推移 ・オピオイド耐性治療の中国市場規模推移 ・オピオイド耐性治療の韓国市場規模推移 ・オピオイド耐性治療のインド市場規模推移 ・オピオイド耐性治療の東南アジア市場規模推移 ・オピオイド耐性治療の南米市場分析（ブラジル、アルゼンチン等） ・オピオイド耐性治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・オピオイド耐性治療の種類別分析/販売量、売上、市場シェア（NMDA拮抗薬、α2 - アドレナリン受容体作動薬） ・オピオイド耐性治療の用途別分析/市場規模（病院・外来手術センター、リハビリテーションセンター） ・オピオイド耐性治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・オピオイド耐性治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Opioids are effective analgesics prescribed to people with chronic cancer and severe pain. These opioids are generally used for short period of time. If these opioids are prescribed or taken for a longer period of time or more frequent daily doses, they create opioid tolerance in patients and hence, analgesia or desired therapeutic response is not received.
Scope of the Report:
The worldwide market for Opioid Tolerance Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Opioid Tolerance Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boehringer Ingelheim International
GlaxoSmithKline
Teva Pharmaceutical Industries
Mylan
Otsuka Pharmaceutical
Johnson & Johnson Services
Aurobindo Pharma
Pfizer
Acorda Therapeutics
Zydus Cadila
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NMDA Antagonists
Alpha2-Adrenoceptor Agonists
Market Segment by Applications, can be divided into
Hospitals and Ambulatory Surgery Centers
Rehabilitation Centers
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioid Tolerance Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioid Tolerance Treatment, with price, sales, revenue and global market share of Opioid Tolerance Treatment in 2017 and 2018.
Chapter 3, the Opioid Tolerance Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioid Tolerance Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Opioid Tolerance Treatment market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Opioid Tolerance Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Opioid Tolerance Treatment Introduction
1.2 Market Analysis by Type
1.2.1 NMDA Antagonists
1.2.2 Alpha2-Adrenoceptor Agonists
1.3 Market Analysis by Applications
1.3.1 Hospitals and Ambulatory Surgery Centers
1.3.2 Rehabilitation Centers
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim International
2.1.1 Business Overview
2.1.2 Opioid Tolerance Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Opioid Tolerance Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Teva Pharmaceutical Industries
2.3.1 Business Overview
2.3.2 Opioid Tolerance Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Mylan
2.4.1 Business Overview
2.4.2 Opioid Tolerance Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mylan Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Otsuka Pharmaceutical
2.5.1 Business Overview
2.5.2 Opioid Tolerance Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Johnson & Johnson Services
2.6.1 Business Overview
2.6.2 Opioid Tolerance Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Services Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Aurobindo Pharma
2.7.1 Business Overview
2.7.2 Opioid Tolerance Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Aurobindo Pharma Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Opioid Tolerance Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Acorda Therapeutics
2.9.1 Business Overview
2.9.2 Opioid Tolerance Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Acorda Therapeutics Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Zydus Cadila
2.10.1 Business Overview
2.10.2 Opioid Tolerance Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Zydus Cadila Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Opioid Tolerance Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Opioid Tolerance Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Opioid Tolerance Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Opioid Tolerance Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Opioid Tolerance Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Opioid Tolerance Treatment Market Analysis by Regions
4.1 Global Opioid Tolerance Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Opioid Tolerance Treatment Sales and Market Share by Regions (2014-2019)
4.1.2 Global Opioid Tolerance Treatment Revenue and Market Share by Regions (2014-2019)
4.2 North America Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
4.3 Europe Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
4.5 South America Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
5 North America Opioid Tolerance Treatment by Country
5.1 North America Opioid Tolerance Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Opioid Tolerance Treatment Sales and Market Share by Country (2014-2019)
5.1.2 North America Opioid Tolerance Treatment Revenue and Market Share by Country (2014-2019)
5.2 United States Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
5.3 Canada Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
5.4 Mexico Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
6 Europe Opioid Tolerance Treatment by Country
6.1 Europe Opioid Tolerance Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Opioid Tolerance Treatment Sales and Market Share by Country (2014-2019)
6.1.2 Europe Opioid Tolerance Treatment Revenue and Market Share by Country (2014-2019)
6.2 Germany Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
6.3 UK Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
6.4 France Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
6.5 Russia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
6.6 Italy Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
7 Asia-Pacific Opioid Tolerance Treatment by Country
7.1 Asia-Pacific Opioid Tolerance Treatment Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Opioid Tolerance Treatment Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Opioid Tolerance Treatment Revenue and Market Share by Country (2014-2019)
7.2 China Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
7.3 Japan Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
7.4 Korea Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
7.5 India Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
8 South America Opioid Tolerance Treatment by Country
8.1 South America Opioid Tolerance Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Opioid Tolerance Treatment Sales and Market Share by Country (2014-2019)
8.1.2 South America Opioid Tolerance Treatment Revenue and Market Share by Country (2014-2019)
8.2 Brazil Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
8.3 Argentina Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
8.4 Colombia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
9 Middle East and Africa Opioid Tolerance Treatment by Countries
9.1 Middle East and Africa Opioid Tolerance Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Opioid Tolerance Treatment Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Opioid Tolerance Treatment Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
9.3 Turkey Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
9.4 Egypt Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
9.5 Nigeria Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
9.6 South Africa Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
10 Global Opioid Tolerance Treatment Market Segment by Type
10.1 Global Opioid Tolerance Treatment Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Opioid Tolerance Treatment Sales and Market Share by Type (2014-2019)
10.1.2 Global Opioid Tolerance Treatment Revenue and Market Share by Type (2014-2019)
10.2 NMDA Antagonists Sales Growth and Price
10.2.1 Global NMDA Antagonists Sales Growth (2014-2019)
10.2.2 Global NMDA Antagonists Price (2014-2019)
10.3 Alpha2-Adrenoceptor Agonists Sales Growth and Price
10.3.1 Global Alpha2-Adrenoceptor Agonists Sales Growth (2014-2019)
10.3.2 Global Alpha2-Adrenoceptor Agonists Price (2014-2019)
11 Global Opioid Tolerance Treatment Market Segment by Application
11.1 Global Opioid Tolerance Treatment Sales Market Share by Application (2014-2019)
11.2 Hospitals and Ambulatory Surgery Centers Sales Growth (2014-2019)
11.3 Rehabilitation Centers Sales Growth (2014-2019)
12 Opioid Tolerance Treatment Market Forecast (2019-2024)
12.1 Global Opioid Tolerance Treatment Sales, Revenue and Growth Rate (2019-2024)
12.2 Opioid Tolerance Treatment Market Forecast by Regions (2019-2024)
12.2.1 North America Opioid Tolerance Treatment Market Forecast (2019-2024)
12.2.2 Europe Opioid Tolerance Treatment Market Forecast (2019-2024)
12.2.3 Asia-Pacific Opioid Tolerance Treatment Market Forecast (2019-2024)
12.2.4 South America Opioid Tolerance Treatment Market Forecast (2019-2024)
12.2.5 Middle East and Africa Opioid Tolerance Treatment Market Forecast (2019-2024)
12.3 Opioid Tolerance Treatment Market Forecast by Type (2019-2024)
12.3.1 Global Opioid Tolerance Treatment Sales Forecast by Type (2019-2024)
12.3.2 Global Opioid Tolerance Treatment Market Share Forecast by Type (2019-2024)
12.4 Opioid Tolerance Treatment Market Forecast by Application (2019-2024)
12.4.1 Global Opioid Tolerance Treatment Sales Forecast by Application (2019-2024)
12.4.2 Global Opioid Tolerance Treatment Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Opioid Tolerance Treatment Picture
Table Product Specifications of Opioid Tolerance Treatment
Figure Global Sales Market Share of Opioid Tolerance Treatment by Types in 2018
Table Opioid Tolerance Treatment Types for Major Manufacturers
Figure NMDA Antagonists Picture
Figure Alpha2-Adrenoceptor Agonists Picture
Figure Opioid Tolerance Treatment Sales Market Share by Applications in 2018
Figure Hospitals and Ambulatory Surgery Centers Picture
Figure Rehabilitation Centers Picture
Figure United States Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure France Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure UK Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure China Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure India Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Opioid Tolerance Treatment Revenue (Value) and Growth Rate (2014-2024)
Table Boehringer Ingelheim International Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim International Opioid Tolerance Treatment Type and Applications
Table Boehringer Ingelheim International Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Opioid Tolerance Treatment Type and Applications
Table GlaxoSmithKline Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Opioid Tolerance Treatment Type and Applications
Table Teva Pharmaceutical Industries Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Opioid Tolerance Treatment Type and Applications
Table Mylan Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Opioid Tolerance Treatment Type and Applications
Table Otsuka Pharmaceutical Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Services Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Services Opioid Tolerance Treatment Type and Applications
Table Johnson & Johnson Services Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Opioid Tolerance Treatment Type and Applications
Table Aurobindo Pharma Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Opioid Tolerance Treatment Type and Applications
Table Pfizer Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Acorda Therapeutics Basic Information, Manufacturing Base and Competitors
Table Acorda Therapeutics Opioid Tolerance Treatment Type and Applications
Table Acorda Therapeutics Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table Zydus Cadila Opioid Tolerance Treatment Type and Applications
Table Zydus Cadila Opioid Tolerance Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Opioid Tolerance Treatment Sales by Manufacturer (2017-2018)
Figure Global Opioid Tolerance Treatment Sales Market Share by Manufacturer in 2017
Figure Global Opioid Tolerance Treatment Sales Market Share by Manufacturer in 2018
Table Global Opioid Tolerance Treatment Revenue by Manufacturer (2017-2018)
Figure Global Opioid Tolerance Treatment Revenue Market Share by Manufacturer in 2017
Figure Global Opioid Tolerance Treatment Revenue Market Share by Manufacturer in 2018
Figure Top 3 Opioid Tolerance Treatment Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Opioid Tolerance Treatment Manufacturer (Revenue) Market Share in 2018
Figure Global Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Global Opioid Tolerance Treatment Revenue and Growth Rate (2014-2019)
Table Global Opioid Tolerance Treatment Sales by Regions (2014-2019)
Table Global Opioid Tolerance Treatment Sales Market Share by Regions (2014-2019)
Table Global Opioid Tolerance Treatment Revenue by Regions (2014-2019)
Figure Global Opioid Tolerance Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Opioid Tolerance Treatment Revenue Market Share by Regions in 2018
Figure North America Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Europe Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure South America Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure North America Opioid Tolerance Treatment Revenue and Growth Rate (2014-2019)
Table North America Opioid Tolerance Treatment Sales by Countries (2014-2019)
Table North America Opioid Tolerance Treatment Sales Market Share by Countries (2014-2019)
Figure North America Opioid Tolerance Treatment Sales Market Share by Countries (2014-2019)
Figure North America Opioid Tolerance Treatment Sales Market Share by Countries in 2018
Table North America Opioid Tolerance Treatment Revenue by Countries (2014-2019)
Table North America Opioid Tolerance Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Opioid Tolerance Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Opioid Tolerance Treatment Revenue Market Share by Countries in 2018
Figure United States Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Canada Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Mexico Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Europe Opioid Tolerance Treatment Revenue and Growth Rate (2014-2019)
Table Europe Opioid Tolerance Treatment Sales by Countries (2014-2019)
Table Europe Opioid Tolerance Treatment Sales Market Share by Countries (2014-2019)
Table Europe Opioid Tolerance Treatment Revenue by Countries (2014-2019)
Figure Europe Opioid Tolerance Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Opioid Tolerance Treatment Revenue Market Share by Countries in 2018
Figure Germany Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure UK Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure France Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Russia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Italy Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Opioid Tolerance Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Opioid Tolerance Treatment Sales by Countries (2014-2019)
Table Asia-Pacific Opioid Tolerance Treatment Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Opioid Tolerance Treatment Sales Market Share by Countries 2018
Table Asia-Pacific Opioid Tolerance Treatment Revenue by Countries (2014-2019)
Figure Asia-Pacific Opioid Tolerance Treatment Revenue Market Share by Countries 2018
Figure China Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Japan Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Korea Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure India Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Southeast Asia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure South America Opioid Tolerance Treatment Revenue and Growth Rate (2014-2019)
Table South America Opioid Tolerance Treatment Sales by Countries (2014-2019)
Table South America Opioid Tolerance Treatment Sales Market Share by Countries (2014-2019)
Figure South America Opioid Tolerance Treatment Sales Market Share by Countries in 2018
Table South America Opioid Tolerance Treatment Revenue by Countries (2014-2019)
Table South America Opioid Tolerance Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Opioid Tolerance Treatment Revenue Market Share by Countries in 2018
Figure Brazil Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Argentina Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Colombia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Opioid Tolerance Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Opioid Tolerance Treatment Sales by Countries (2014-2019)
Table Middle East and Africa Opioid Tolerance Treatment Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Tolerance Treatment Sales Market Share by Countries in 2018
Table Middle East and Africa Opioid Tolerance Treatment Revenue by Countries (2014-2019)
Table Middle East and Africa Opioid Tolerance Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Tolerance Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Tolerance Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure UAE Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Egypt Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure Nigeria Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Figure South Africa Opioid Tolerance Treatment Sales and Growth Rate (2014-2019)
Table Global Opioid Tolerance Treatment Sales by Type (2014-2019)
Table Global Opioid Tolerance Treatment Sales Share by Type (2014-2019)
Table Global Opioid Tolerance Treatment Revenue by Type (2014-2019)
Table Global Opioid Tolerance Treatment Revenue Share by Type (2014-2019)
Figure Global NMDA Antagonists Sales Growth (2014-2019)
Figure Global NMDA Antagonists Price (2014-2019)
Figure Global Alpha2-Adrenoceptor Agonists Sales Growth (2014-2019)
Figure Global Alpha2-Adrenoceptor Agonists Price (2014-2019)
Table Global Opioid Tolerance Treatment Sales by Application (2014-2019)
Table Global Opioid Tolerance Treatment Sales Share by Application (2014-2019)
Figure Global Rehabilitation Centers Sales Growth (2014-2019)
Figure Global Opioid Tolerance Treatment Sales, Revenue and Growth Rate (2019-2024)
Table Global Opioid Tolerance Treatment Sales Forecast by Regions (2019-2024)
Table Global Opioid Tolerance Treatment Market Share Forecast by Regions (2019-2024)
Figure North America Sales Opioid Tolerance Treatment Market Forecast (2019-2024)
Figure Europe Sales Opioid Tolerance Treatment Market Forecast (2019-2024)
Figure Asia-Pacific Sales Opioid Tolerance Treatment Market Forecast (2019-2024)
Figure South America Sales Opioid Tolerance Treatment Market Forecast (2019-2024)
Figure Middle East and Africa Sales Opioid Tolerance Treatment Market Forecast (2019-2024)
Table Global Opioid Tolerance Treatment Sales Forecast by Type (2019-2024)
Table Global Opioid Tolerance Treatment Market Share Forecast by Type (2019-2024)
Table Global Opioid Tolerance Treatment Sales Forecast by Application (2019-2024)
Table Global Opioid Tolerance Treatment Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
β1アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β1 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …- β2アドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β2 Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …
- βアドレナリン受容体作動薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global β Adrenoceptor Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
- 便秘治療薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Constipation Treatment Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Constipation Treatmen…
- 鍵穴整形外科手術の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Keyhole orthopaedic surgery is a minimally invasive procedure which examine and repairs the damage of the bones, cartilage and ligaments surgically. Scope of the Report: The global Keyhole Orthopaedic Surgery market is valued at xx million USD in 2018 and is expected to reach xx million USD by the e…